Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The three-dimensional structure of the 146-residue form of human basic fibroblast growth factor (bFGF), expressed as a recombinant protein in yeast, has been determined by x-ray crystallography to a resolution of 1.8 A. bFGF is composed entirely of beta-sheet structure, comprising a three-fold repeat of a four-stranded antiparallel beta-meander. The topology of bFGF is identical to that of interleukin 1 beta, showing that although the two proteins share only 10% sequence identity, bFGF, interleukin 1, and their homologs comprise a family of structurally related mitogenic factors. Analysis of the three-dimensional structure in light of functional studies of bFGF suggests that the receptor binding site and the positively charged heparin binding site correspond to adjacent but separate loci on the beta-barrel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
Crystallographic R Factor Refinement by Molecular Dynamics
Brünger, A. T., Kuriyan, J., & Karplus, M. (1987) · Science · doi:10.1126/science.235.4787.458 · Cited by 1,956
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
Human KGF is FGF-Related with Properties of a Paracrine Effector of Epithelial Cell Growth
Finch, P. W., Rubin, J. S., Miki, T., Ron, D., & Aaronson, S. A. (1989) · Science · doi:10.1126/science.2475908 · Cited by 984
Heparin protects basic and acidic FGF from inactivation
Gospodarowicz, D., & Cheng, J. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280317 · Cited by 853
Using known substructures in protein model building and crystallography.
Jones, T. A., & Thirup, S. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04287.x · Cited by 758
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Purification and Complementary DNA Cloning of a Receptor for Basic Fibroblast Growth Factor
Lee, P. L., Johnson, D. E., Cousens, L. S., Fried, V. A., & Williams, L. T. (1989) · Science · doi:10.1126/science.2544996 · Cited by 648
Self-citationDionne, C. A., Crumley, G., Bellot, F., Kaplow, J. M., Searfoss, G., Ruta, M., Burgess, W. H., Jaye, M., & Schlessinger, J. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07454.x · Cited by 622
Cited by
Fibroblast growth factors, their receptors and signaling
Powers, C. J., McLeskey, S. W., & Wellstein, A. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070165 · Cited by 1,332
The Fgf Family of Growth Factors and Oncogenes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60305-x · Cited by 1,145
Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606854104 · Cited by 966
Heparin Structure and Interactions with Basic Fibroblast Growth Factor
Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., & Rees, D. C. (1996) · Science · doi:10.1126/science.271.5252.1116 · Cited by 798
Structural basis for fibroblast growth factor receptor activation
Mohammadi, M., Olsen, S. K., & Ibrahimi, O. A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.008 · Cited by 735
Structural Basis for FGF Receptor Dimerization and Activation
Plotnikov, A. N., Schlessinger, J., Hubbard, S. R., & Mohammadi, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80051-3 · Cited by 609
Saenz, S. A., Taylor, B. C., & Artis, D. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00713.x · Cited by 484
Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
Maccarana, M., Casu, B., & Lindahl, U. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80470-0 · Cited by 454
Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.
Webb, L. M., Ehrengruber, M. U., Clark-Lewis, I., Baggiolini, M., & Rot, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7158 · Cited by 442
Cai, S., Liu, Y., Zheng Shu, X., & Prestwich, G. D. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.012 · Cited by 422
RANK Ligand and Osteoprotegerin: Paracrine Regulators of Bone Metabolism and Vascular Function
Schoppet, M., Preissner, K. T., & Hofbauer, L. C. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000012303.37971.da · Cited by 405
Smallwood, P. M., Munoz-Sanjuan, I., Tong, P., Macke, J. P., Hendry, S. H., Gilbert, D. J., Copeland, N. G., Jenkins, N. A., & Nathans, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9850 · Cited by 396
The Heparan Sulfate–Fibroblast Growth Factor Family: Diversity of Structure and Function
McKeehan, W. L., Wang, F., & Kan, M. (1997) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)61031-4 · Cited by 392
Enzymatic Degradation of GlycosaminogIycans
Ernst, S., Langer, R., Cooney, C. L., & Sasisekharan, R. (1995) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239509083490 · Cited by 387
Lin, X., Buff, E. M., Perrimon, N., & Michelson, A. M. (1999) · Development · doi:10.1242/dev.126.17.3715 · Cited by 367
Guvakova, M. A., Yakubov, L. A., Vlodavsky, I., Tonkinson, J. L., & Stein, C. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2620 · Cited by 326
Murzin, A. G., Lesk, A. M., & Chothia, C. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90668-a · Cited by 322
Pike, D. B., Cai, S., Pomraning, K. R., Firpo, M. A., Fisher, R. J., Shu, X. Z., Prestwich, G. D., & Peattie, R. A. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.018 · Cited by 316
Cytokine dysregulation in autism spectrum disorders (ASD): Possible role of the environment
Goines, P. E., & Ashwood, P. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.07.006 · Cited by 314
De novo design of the hydrophobic cores of proteins
Desjarlais, J. R., & Handel, T. M. (1995) · Protein Science · doi:10.1002/pro.5560041006 · Cited by 306
Thompson, L. D., Pantoliano, M. W., & Springer, B. A. (1994) · Biochemistry · doi:10.1021/bi00179a006 · Cited by 302
Three-dimensional structure of human basic fibroblast growth factor.
Eriksson, A. E., Cousens, L. S., Weaver, L. H., & Matthews, B. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3441 · Cited by 284
Self-citationMolecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
Belov, A. A., & Mohammadi, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a015958 · Cited by 271
Extracellular Matrix and Cytokines: A Functional Unit
Schönherr, E., & Hausser, H.-J. (2000) · Journal of Immunology Research · doi:10.1155/2000/31748 · Cited by 268
FGF Binding and FGF Receptor Activation by Synthetic Heparan-Derived Di- and Trisaccharides
Ornitz, D. M., Herr, A. B., Nilsson, M., Westman, J., Svahn, C.-M., & Waksman, G. (1995) · Science · doi:10.1126/science.7536345 · Cited by 267
Demonstration of Positionally Disordered Water Within a Protein Hydrophobic Cavity by NMR
Ernst, J. A., Clubb, R. T., Zhou, H.-X., Gronenborn, A. M., & Clore, G. M. (1995) · Science · doi:10.1126/science.7892604 · Cited by 265
Roghani, M., Mansukhani, A., Dell'Era, P., Bellosta, P., Basilico, C., Rifkin, D. B., & Moscatelli, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41730-3 · Cited by 261
Cytokine structural taxonomy and mechanisms of receptor engagement
Sprang, S. R., & Fernando Bazan, J. (1993) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(93)90144-a · Cited by 256
Self-citation(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)91003-2 · Cited by 239
“…12 antiparallel strands in which three pairs of the strands form a -barrel structure, and the other three pairs cap the barrel with hairpin triplets, forming a triangular array (Ago et al., 1991; Blaber et al., 1996; Eriksson et al., 1991; Graves et al., 1990; Zhang et al., 1991; Zhu et al., 1991).”
BackgroundWissink, M. J. B., Beernink, R., Poot, A. A., Engbers, G. H. M., Beugeling, T., van Aken, W. G., & Feijen, J. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00145-5 · Cited by 238
Fibroblast growth factors and their receptors
Galzie, Z., Kinsella, A. R., & Smith, J. A. (1997) · Biochemistry and Cell Biology · doi:10.1139/bcb-75-6-669 · Cited by 214
Dowd, C. J., Cooney, C. L., & Nugent, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5236 · Cited by 168
The Structural Biology of the FGF19 Subfamily
Beenken, A., & Mohammadi, M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0887-1_1 · Cited by 93
A heparin mimetic isolated from a marine shrimp suppresses neovascularization
DREYFUSS, J. L., REGATIERI, C. V., LIMA, M. A., PAREDES‐GAMERO, E. J., BRITO, A. S., CHAVANTE, S. F., BELFORT JR, R., FARAH, M. E., & NADER, H. B. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03916.x · Cited by 38
Metadata
- Authors
- Zhang, J. D., Cousens, L. S., Barr, P. J., & Sprang, S. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-04-15
- Volume
- 88
- Issue
- 8
- Pages
- 3446-3450
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2028545463
- Cited by
- 250
- References
- 33
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.